These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10550992)

  • 41. Contribution of conserved glycine residues to ATP action at human P2X1 receptors: mutagenesis indicates that the glycine at position 250 is important for channel function.
    Digby HR; Roberts JA; Sutcliffe MJ; Evans RJ
    J Neurochem; 2005 Dec; 95(6):1746-54. PubMed ID: 16236030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular determinants of the agonist binding domain of a P2X receptor channel.
    Yan Z; Liang Z; Tomic M; Obsil T; Stojilkovic SS
    Mol Pharmacol; 2005 Apr; 67(4):1078-88. PubMed ID: 15632318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developments in P2 receptor targeted therapeutics.
    Williams M
    Prog Brain Res; 1999; 120():93-106. PubMed ID: 10550990
    [No Abstract]   [Full Text] [Related]  

  • 44. Molecular biology of P2Y receptors expressed in the nervous system.
    Webb TE; Barnard EA
    Prog Brain Res; 1999; 120():23-31. PubMed ID: 10550985
    [No Abstract]   [Full Text] [Related]  

  • 45. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
    Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of ATP-gated P2X7 receptors in fish provides new insights into the mechanism of release of the leaderless cytokine interleukin-1 beta.
    López-Castejón G; Young MT; Meseguer J; Surprenant A; Mulero V
    Mol Immunol; 2007 Feb; 44(6):1286-99. PubMed ID: 16837047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neighboring glycine residues are essential for P2X2 receptor/channel function.
    Nakazawa K; Ohno Y
    Eur J Pharmacol; 1999 Apr; 370(3):R5-6. PubMed ID: 10334514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenosine and ATP: from receptor structure to clinical applications.
    Kennedy C; IJzerman A
    Trends Pharmacol Sci; 1994 Sep; 15(9):311-2. PubMed ID: 7992379
    [No Abstract]   [Full Text] [Related]  

  • 49. Contribution of conserved polar glutamine, asparagine and threonine residues and glycosylation to agonist action at human P2X1 receptors for ATP.
    Roberts JA; Evans RJ
    J Neurochem; 2006 Feb; 96(3):843-52. PubMed ID: 16371009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of the left-flipper-to-dorsal-fin interface of the zebrafish P2X4 receptor in ATP binding and structural rearrangement.
    Jie Y; Zhang L; Xu H; Gao C; Ma W; Li Z
    Neurosci Lett; 2014 Oct; 582():1-5. PubMed ID: 25175421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [ATP and neuropathic pain].
    Inoue K; Tsuda M; Koizumi S
    Seikagaku; 2004 Nov; 76(11):1431-9. PubMed ID: 15626030
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacological characterization of P2X7 receptors in rat peritoneal cells.
    Chen YW; Donnelly-Roberts DL; Namovic MT; Gintant GA; Cox BF; Jarvis MF; Harris RR
    Inflamm Res; 2005 Mar; 54(3):119-26. PubMed ID: 15883745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The antibiotic polymyxin B modulates P2X7 receptor function.
    Ferrari D; Pizzirani C; Adinolfi E; Forchap S; Sitta B; Turchet L; Falzoni S; Minelli M; Baricordi R; Di Virgilio F
    J Immunol; 2004 Oct; 173(7):4652-60. PubMed ID: 15383600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A highly conserved tryptophane residue indispensable for cloned rat neuronal P2X receptor activation.
    Nakazawa K; Ojima H; Ohno Y
    Neurosci Lett; 2002 May; 324(2):141-4. PubMed ID: 11988347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Signaling at purinergic P2X receptors.
    Surprenant A; North RA
    Annu Rev Physiol; 2009; 71():333-59. PubMed ID: 18851707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. P2Y(11), a purinergic receptor acting via cAMP, mediates secretion by pancreatic duct epithelial cells.
    Nguyen TD; Meichle S; Kim US; Wong T; Moody MW
    Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G795-804. PubMed ID: 11292586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. P2X(1) receptor subunit contribution to gating revealed by a dominant negative PKC mutant.
    Ennion SJ; Evans RJ
    Biochem Biophys Res Commun; 2002 Mar; 291(3):611-6. PubMed ID: 11855833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of ectodomain regions contributing to gating, deactivation, and resensitization of purinergic P2X receptors.
    Zemkova H; He ML; Koshimizu TA; Stojilkovic SS
    J Neurosci; 2004 Aug; 24(31):6968-78. PubMed ID: 15295032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular modeling as a tool to investigate molecular recognition in P2Y receptors.
    Moro S; Jacobson KA
    Curr Pharm Des; 2002; 8(26):2401-13. PubMed ID: 12369952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adenosine and P2 receptors in PC12 cells. Genotypic, phenotypic and individual differences.
    Arslan G; Fredholm BB
    Prog Brain Res; 1999; 120():301-10. PubMed ID: 10551006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.